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Background
Alexithymia is a personality trait characterized by the inabil-
ity to identify and express emotions. Neuroimaging studies
showed specific neural correlates in alexithymic subjects [1]
and pathological scores of alexithymia in several chronic
pain populations and in episodic migraine [2,3]. There is
also evidence of a positive association between alexithymia,
depression, and anxiety in migraine patients. So far, no
study has evaluated alexithymia in medication-overuse
headache patients (MOH) (progressed by migraine) versus
episodic migraine patients (MIG). The present study was
aimed to evaluate whether MOH individuals differ from
MIG as regards alexithymia scores and to investigate the
association of alexithymia with headache characteristics.
Materials and methods
We recruited 99 patients suffering from MOH (n=54;
81.5% female; age: 41.6±10.9) evolved from migraine
(chronic migraine + MOH) or MIG (n=45; 71.6% female;
age: 41.0±9.3) at the Headache Centre of the “Mondino”
Institute of Pavia. Diagnosis in the 2 groups was opera-
tionally defined according to the ICHD-IIIb criteria.
Patients were evaluated using the Toronto Alexithymia
Scale (TAS-20), which uses a five-point Likert response
scale and has a three-factor structure consisting of: (1) Dif-
ficulty in identifying feelings, (2) Difficulty in describing
feeling, and (3) Externally oriented thinking. Demographic
and clinical information were collected as well.
Results
According to multiple binary logistic regression analysis,
MIG and MOH patients were comparable in terms of
demographic characteristics, whereas they differed for
some characteristics of illness (age of migraine onset,
duration of illness, frequency of headache), disability and
QoL, as well as for depression levels. MOH patients
scored higher than MIG on two of the three alexithymia
facets, which were those concerning difficulties in identi-
fying (MOH = 19.1±6.7, MIG = 13.8±6.7, p < 0.001) and
describing feelings (MOH = 14.4±4.5, MIG = 11.6±4.8,
p = 0.003). Groups were instead comparable in terms of
externally oriented thinking (MOH = 18.6±4.2, MIG =
18.0±4.1, p = 0.50). Significant correlations resulted
between alexithymia and illness characteristics (e.g.,
headache frequency, perceived disability, and QoL).
Conclusions
Our results show a specific alexithymic profile in our
MOH population. These findings suggest that alexithy-
mia could represent a risk factor in the transformation
from episodic migraine into the chronic subtype with
medication overuse. Early and appropriate interventions
aimed at improving emotional awareness and expression
could then represent a further preventive measure to
avoid drug-induced headache.
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